Journal of Occupational
Health and Epidemiology
Rafsanjan university Of medical sciences
Volume 8, Issue 4 (Autumn 2019)
J Occup Health Epidemiol 2019, 8(4): 171-175 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hatami H, Movafagh P, Ramezankhani A. An Investigation of the Immune Response to Hepatitis B Vaccination in Hemodialysis Patients at Dialysis Centers of Tehran (2016) . J Occup Health Epidemiol 2019; 8 (4) :171-175
URL: http://johe.rums.ac.ir/article-1-366-en.html
URL: http://johe.rums.ac.ir/article-1-366-en.html
Related article in
Google Scholar
Google Scholar
Similar articles
1- Prof. of Infectious and Tropical Diseases and Master of Public Health (MPH), Dept. of Public Health, School of Health and Environmental and Occupational Hazard Control Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Master of Public Health (MPH), Dept. of Public Health, School of Public Health and Immunity, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , pmovafag@yahoo.com
3- Prof. of Health Education & Health Promotion, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Master of Public Health (MPH), Dept. of Public Health, School of Public Health and Immunity, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , pmovafag@yahoo.com
3- Prof. of Health Education & Health Promotion, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article history
Received: 2019/09/27
Accepted: 2020/05/6
ePublished: 2020/09/23
Accepted: 2020/05/6
ePublished: 2020/09/23
Subject:
Epidemiology
Abstract: (1639 Views)
Background: Hemodialysis (HD) patients are at an increased risk of acquiring the hepatitis B (HB) virus and having lower protective antibody levels as well as shorter durations of seroprotection. This study aims to determine the immune response of HB vaccination in HD patients referring to dialysis centers of the Tehran North Health Network.
Materials and Methods: This descriptive study was conducted among all HD patients who referred to dialysis centers of the Tehran North Health Network in 2016. A total of 304 HD patients were included in this study using the census sampling method. Data were collected using a checklist, and the HBsAb level was evaluated by the ELISA test. The collected data were analyzed using analytical tests, including a chi-square test and the independent t-test.
Results: The mean±sd values of the serum level of HBsAb were 90.44±97.51 and 105.73±100 IU/L in men and women, respectively. There was no association between the rate of the response to the HB vaccine and gender (P=0.82), age (P=0.13), weight (P=0.09), vaccine injection frequency (P=0.45), number of dialysis sessions/week (P=0.36), and blood type (P=0.97). In addition, there was no association between the response to the HB vaccine and the history of T2DM, HTN, renal transplantation, and cigarette smoking among the participants (P>0.05).
Conclusion: One could conclude that the dialysis duration and the last injection of the HB vaccine would have a negative effect on the immune response rate among HD patients.
Materials and Methods: This descriptive study was conducted among all HD patients who referred to dialysis centers of the Tehran North Health Network in 2016. A total of 304 HD patients were included in this study using the census sampling method. Data were collected using a checklist, and the HBsAb level was evaluated by the ELISA test. The collected data were analyzed using analytical tests, including a chi-square test and the independent t-test.
Results: The mean±sd values of the serum level of HBsAb were 90.44±97.51 and 105.73±100 IU/L in men and women, respectively. There was no association between the rate of the response to the HB vaccine and gender (P=0.82), age (P=0.13), weight (P=0.09), vaccine injection frequency (P=0.45), number of dialysis sessions/week (P=0.36), and blood type (P=0.97). In addition, there was no association between the response to the HB vaccine and the history of T2DM, HTN, renal transplantation, and cigarette smoking among the participants (P>0.05).
Conclusion: One could conclude that the dialysis duration and the last injection of the HB vaccine would have a negative effect on the immune response rate among HD patients.
References
1. Farag SE, Ghonemy TA, Soliman1 SA, Bihery A. Evaluation of hepatitis B vaccine responsiveness in hemodialysis and peritoneal dialysis patients. International Journal of Research in Medical Sciences 2015; 3(9):2259-63. [Article] [DOI]
2. World Health Organization. Hepatitis B: Fact sheet. Geneva, Switzerland: World Health Organization; 2020 July. Available from:https://www.who.int/news-room/fact-sheets/detail/hepatitis-b [Report]
3. Shamshirian A, Alikhani S, Alipoor R, Jafarpour H, Espahbodi F, Azizi S. Evaluation of immunogenicity of hepatitis B vaccine in hemodialysis patients at Mazandaran Heart Center, Iran. Biomedical & Pharmacology Journal 2017; 10(2):557-62. [Article] [DO]
4. Mohammadi Z, Keshtkar A, Eghtesad S, Jeddian A, Pourfatholah AA, Maghsudlu M, et al. Epidemiological Profie of Hepatitis B Virus Infection in Iran in the Past 25 years; a Systematic Review and Meta-analysis of General Population Studies. Middle East J Dig Dis 2016; 8(1):5-18. [DOI] [PMID] [PMCID]
5. Ghadiani MH, Besharati Sh, Mousavinasab N, Jalalzadeh M. Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients. J Res Med Sci 2012; 17(6):527-33. [PMID] [PMCID]
6. Kong NCT, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 2008; 73(7):856-62. [DOI] [PMID]
7. Barraclough KA, Playford EG. Hepatitis B virus infection in hemodialysis populations: progress toward prevention. Kidney Int 2010; 77(3):177-80. [DOI] [PMID]
8. Jodłowska-Siewert E, Jagodziński PP, Grzegorzewska AE. Titers of antibodies tothe surface antigen of hepatitis B virus after vaccination in relation toimmunity-related gene variants. A prospective study among hemodialysis patients. Pol Arch Intern Med 2017; 127(7-8):481-9. [DOI] [PMID]
9. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination inhemodialysis patients. Vaccine 2004; 22(29-30):3963-7. [DOI] [PMID]
10. Cordeiro VM, Martins BCT, Teles SA, Martins RMB, Cruvinel KPS, Matos MAD, et al. Decline in hepatitis B and C prevalence among hemodialysis patients in Tocantins, Northern Brazil. Rev Inst Med Trop Sao Paulo 2018; 60:e36. [DOI] [PMID] [PMCID]
11. Guimarães MNC, Facincani T, Santos SSD. Hepatitis B status in hemodialysispatients. Arq Gastroenterol 2017; 54(4):356-8. [DOI] [PMID]
12. Djalalinia Sh, Ramezan Ghorbani N, Tajbakhsh R, Modirian M, Esmaeili Abdar Z, Mahdavi Gorabi A, et al. Hepatitis B Virus Infection in Iranian Hemodialysis Patients: a Systematic Review and Meta-Analysis. Iran J Kidney Dis 2018; 12(1):1-9. [PMID]
13. Ayub MA, Bacci MR, Fonseca FLA, Chehter EZ. Hemodialysis and hepatitis B vaccination: a challenge to physicians. Int J Gen Med 2014; 7:109-14. [DOI] [PMID] [PMCID]
14. Malaki M. Factors affecting on hepatitis B seroprotection in hemodialysis patients. Saudi J Kidney Dis Transpl 2017; 28(3):672-4. [DOI] [PMID]
15. Gasim GI, Bella A, Adam I. Immune response to hepatitis B vaccine among patients on hemodialysis. World J Hepatol 2015; 7(2):270-5. [DOI] [PMID] [PMCID]
16. Sit D, Esen B, Atay AE, Kayabaşı H. Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World J Hepatol. 2015; 7(5):761-8. [DOI] [PMID] [PMCID]
17. Almueilo SH. Evaluation of Response to Hepatitis B Vaccination in Chronic Hemodialysis Patients. Saudi J Med Med Sci 2017; 5(3):218-23. [DOI] [PMID] [PMCID]
18. Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol 2014; 20(34):12018-25. [DOI] [PMID] [PMCID]
19. Mohammed HI, El-Hefenawy SM, Mohamed SF. Assessment of immune response to hepatitis B virus vaccine in chronic hemodialysis patients. Menoufia Medical Journal 2017; 30(1):184-9. [DOI]
20. Pereira ZTV, Mendoza-Sassi RA. Factors associated with the immune response to hepatitis B vaccine in Brazilian hemodialysis patients. Rev Med Chil 2012; 140(7):882-8. [DOI] [PMID]
21. Ponappan S, Ponappan U. Aging and immune function: molecular mechanism to intervention. Antioxid Redox Singal 2011; 14(8):1551-85. [DOI] [PMID] [PMCID]
22. Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care 2012; 35(12):2690-7. [DOI] [PMID] [PMCID]
23. Bonanni P, Bonaccorsi G. Vaccination gainst hepatitis B in health care workers. Vaccine 2001; 19(17-19):2389-94. [DOI] [PMID]
24. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines.Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998; 15(1):1-8. [DOI] [PMID]
25. Barash C, Conn MI, DiMarino Jr AJ, Marzano J, Allen ML. Serologic hepatitis B immunity in vaccinated health care workers. Arch Intern Med 1999; 159(13):1481-3. [DOI] [PMID]
26. Cordova E, Miglia I, Festuccia F, Sarlo MG, Scornavacca G, Punzo G, et al. Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review. Ann Ig 2017; 29(1):27-37. [DOI] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
